SQI Diagnostics to Extend Warrant Expiry
January 14, 2016
Toronto, Ontario -- SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), today announced that it intends to extend the expiry of 2,965,000 outstanding common share purchase warrants (“the Warrants”) of the Company, which [...]
January 14, 2016
Oxford Instruments, a leader in analytical instrumentation for the industrial sector, is pleased to announce that John Kurtz and Wayne Vereb have joined the company to further develop national accounts and new partnerships for OES instrumentation across the United States. These hires bring to Oxford Instruments a wealth of experience within the OES industry and [...]
WiLAN Subsidiary Enters Into License Agreement With FEI
January 13, 2016
OTTAWA, CANADA - WiLAN (TSX:WIN)(NASDAQ:WILN) announced that the Company's subsidiary, Advanced Microscopy, Inc., has entered into a license agreement with FEI Company. The license relates to technology that provides enhanced image processing capabilities. Potential applications relate to the life sciences, material sciences, and semiconductor research. The license resolves litigation pending in the District of Delaware. [...]
ORNL, SCIEX sign license agreement for analytical chemistry tech
January 13, 2016
OAK RIDGE, Tenn. -- The Department of Energy’s Oak Ridge National Laboratory andSCIEX of Framingham, Mass., have signed a licensing agreement for technologies that speed up, simplify and expand the use of analytic chemistry equipment. SCIEX is a leading manufacturer of mass spectrometers used to identify and characterize chemical compounds in a variety of industrial [...]
MKS UMETRICS IS NOW MKS DATA ANALYTICS SOLUTIONS
January 13, 2016
Umea, Sweden, - Effective immediately, MKS Umetrics has changed its name to MKS Data Analytics Solutions. As MKS Umetrics moves into the next phase of our company's development, we are expanding our business proposition and product offering to address new and larger markets. To signal the change, we are taking the opportunity to change our [...]
Organovo Subsidiary Samsara Sciences Launches Commercial Operations
January 13, 2016
SAN DIEGO -- Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo” or the “Company”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that its wholly-owned subsidiary, Samsara Sciences, Inc.(“Samsara”), has launched commercial operations. Samsara’s core mission is the provision of high-quality primary human liver cells for a [...]
January 13, 2016
Woburn, MA - The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies (“Quad”), is meeting this need with its MagCloudzTM Streptavidin Cell Separation Kits and has partnered with The University [...]
January 13, 2016
LA JOLLA, CA –– SGI-DNA, a Synthetic Genomics, Inc. (SGI) company, announced today that the world’s first DNA printer, the BioXp™ 3200 System, has reached another milestone with the release of the BioXp™ cloning module. The addition of the cloning module to the instrument repertoire further solidifies SGI-DNA as an industry leader at the forefront [...]
January 13, 2016
Woburn, MA - The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies (“Quad”), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University [...]
January 13, 2016
Chalfont St. Giles, UK and Toronto, Canada –– GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of CAD $40M from GE and FedDev Ontario. The centre is being [...]
